Can digital skills training empower a diabetes community?
NCT ID NCT07783893
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This pilot study tests a training program designed to improve eHealth literacy—the ability to find and use health information online—among Bangladeshi adults with type 2 diabetes in Ancona, Italy. The program, co-designed with patients and community members, includes four modules covering diabetes, health literacy, and digital skills. Researchers will measure changes in eHealth literacy, health literacy, and diabetes self-confidence before, right after, and at 1 and 6 months after the training to see if improvements last.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Culturally adapted eHealth literacy training program
- What this could lead to
- If effective, this program could help Bangladeshi adults with type 2 diabetes better manage their condition using digital tools, potentially improving health outcomes in this community.
- What could go wrong
- This is a small pilot study with 50 participants, so results may not apply broadly. The training's impact on long-term diabetes control remains uncertain, and participants may face barriers to digital access.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults of Bangladeshi ethnicity with type 2 diabetes mellitus, residing in the Marche Region (Italy) and followed by the diabetes center (Centro Antidiabetico, CAD) of the University Hospital of the Marche Region (Azienda Ospedaliero-Universitaria delle Marche) in Ancona. Participants are recruited from among patients already in active follow-up at this clinic who wish to take part in the study and meet the eligibility criteria, including sufficient Italian language proficiency (CEFR level A2 or above), preserved cognitive status, absence of severe depressive symptoms, and low levels of health literacy, eHealth literacy, or self-efficacy in diabetes management. The Bangladeshi community is one of the largest ethnic minority groups in the Marche Region.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * belonging to Bangladesh ethnicity * affected by DM type 2 (as confirmed by the physician's diagnosis) * Followed by the CAD of the capital province of Marche Region, Ancona, located in Azienda Ospedaliero Universitaria delle Marche * aged \>= 18 years old * Capable of communicating verbally in local language (corresponding to a level of Italian language knowledge =\>A2-CEFR level) (Council of Europe, 1996) * without acute medical problems: myocardial infarction or stroke within 6 months, painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility, advanced Parkinson's disease and/or neuromuscular disorders, metastatic cancer, or immunosuppressive therapy, significant visual or hearing impairment, uncontrolled hypertension or other serious conditions that restrict their participation in the study. * MMSE\>= 24 (Folstein et al. 1975) * PHQ-9=\< 15 (Kroenke et al. 2001) * with a low HL level, assessed by a scoring \<=12 of HLS-EU-Q16 (Pelikan et al. 2017) and/or with low e-HL level, measured through e-HEALS (Norman \& Skinner, 2006-II), assessed by a scoring \<=29, and/or with low levels in self-efficacy, measured IT-DMSES (Messina et al. 2018), assessed by a scoring \<4. * capable to consent * fulfilling the informed consent. Exclusion Criteria: * Failure to meet the inclusion criteria; * Concomitant participation in other studies; * Lack of written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero Universitaria delle Marche (AOU Marche)
Ancona, March, 60126, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cost-Effectiveness and implementation of integrated Diabetes-Oral health care in oman: a health belief Model-Based intervention to enhance clinical, behavioral, and exploratory oral microbiome in health system outcomes in type 2 diabetes
- Fibrinogen to albumin ratio (FAR) as a risk factor for type 2 diabetic Nephropathy(DN)
- A digital coach for hunger: can an app retrain appetite to improve diabetes control?
- Can a High-Protein or High-Fat Low-Carb diet tame blood sugar and triglycerides?
- Can a numbing gel on the feet beat a daily pill for diabetic nerve pain?
- Can a crocosmia bulb compound tame type 2 diabetes?